BeiGene Ltd - ADR
BGNE
Market Cap$12.62B
Close$
$150.03
7.9% upside
Current Fair Value
7.9% upsideUndervalued by 7.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.62 Billion |
|---|---|
| Enterprise Value | $10.33 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-8.45 |
| Beta | 1.18 |
| Outstanding Shares | 95,639,914 |
| Avg 30 Day Volume | 163,506 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -14.31 |
|---|---|
| PEG | 86.4 |
| Price to Sales | 5.56 |
| Price to Book Ratio | 3.86 |
| Enterprise Value to Revenue | 4.2 |
| Enterprise Value to EBIT | -8.56 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
ESG Score
No data
About BeiGene Ltd
CEO: John Oyler